Log on / register
Feedback | Support | My details

Pre-publication history

Substituting abacavir for hyperlipidemia-associated protease inhibitors in HAART regimens improves fasting lipid profiles, maintains virologic suppression, and simplifies treatment

Philip H Keiser email, Michael G Sension email, Edwin DeJesus email, Allan Rodriguez email, Jeffrey F Olliffe email, Vanessa C Williams email, John H Wakeford email, Jerry W Snidow email, Anne D Shachoy-Clark email, Julie W Fleming email, Gary E Pakes email, Jaime E Hernandez email and for the ESS40003 Study Team email

BMC Infectious Diseases 2005, 5:2doi:10.1186/1471-2334-5-2

Pre-publication versions of this article and reviewers' reports

Original submission - Version 1Manuscript02 Mar 2004
Reviewer's ReportLeonardo Calza24 Mar 2004
Reviewer's ReportScott Penzak02 Apr 2004
Resubmission - Version 4ManuscriptAuthors' comments12 Aug 2004
Reviewer's ReportScott Penzak18 Aug 2004
Reviewer's ReportLeonardo Calza23 Aug 2004
Resubmission - Version 5ManuscriptAuthors' comments22 Oct 2004
Resubmission - Version 7Manuscript12 Jan 2005
Accepted12 Jan 2005
Terms and Conditions Privacy statement Information for advertisers Jobs at BMC Contact us
© 1999-2008 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.